Saama Introduces Modular and Adaptive AI Agents for Clinical Innovation
CAMPBELL, Calif., Sept. 29, 2025 /PRNewswire/ -- Saama, an established leader in AI-driven solutions and services within Health Sciences, is introducing...
Vaccine
METiS Launches World’s First AI-Driven Nano-Delivery Platform NanoForge
BEIJING, Sept. 29, 2025 /PRNewswire/ -- METiS TechBio, a pioneer in AI-powered nano-delivery innovation, announced the official launch of NanoForge, the...
dHealth Intelligence Launches Revolutionary AI Agent That Transforms Personal Healthcare Management
ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2025 / Healthcare AI startup dHealth Intelligence just unveiled an AI agent...
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the...
African Leaders Call for Bold, United Action to Tackle Global Health Crises and Sustain Malaria Progress
NEW YORK CITY, NY / ACCESS Newswire / September 26, 2025 / African Heads of State and Government convened global...
SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer
FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII),...
Medical Drones Market Set for 22.19% CAGR from 2025 to 2030, Driven by Expanding Healthcare Delivery Solutions, Says Mordor Intelligence
HYDERABAD, India, Sept. 26, 2025 /PRNewswire/ -- According to a recent report by Mordor Intelligence, the medical drones market size...
Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting
FDA and Capricor aligned on endpoints for HOPE-3 pivotal trialHOPE-3 pivotal trial completed; topline data expected mid-Q4 2025 to support...
Evaxion out-licenses vaccine candidate EVX-B3 to MSD
MSD exercises its option on vaccine candidate EVX-B3 for a cash payment of $7.5 million, which extend Evaxion’s cash runway...
Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made...
The Breast Cancer Research Foundation Awards Record-Breaking $74.75M in Scientific Grants in Year of Exceptional Turmoil in Scientific Funding
BCRF responds to scientific community's urgent need to sustain research NEW YORK, Sept. 24, 2025 /PRNewswire/ -- At a time...
New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every...
Medicus Pharma Ltd. To Present at Brookline Capital Markets
The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell...
WORK Medical Technology Group LTD Partners with Hong Kong Web3.0 Standardization Association to Collaborate on Blockchain and RWA Innovations
Hangzhou, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”),...
Healthcare as the World’s Most Strategic Investment: KFSHRC CEO Calls for Global Collaboration at C3 Japan Summit
Healthcare as the World’s Most Strategic Investment: KFSHRC CEO Calls for Global Collaboration at C3 Japan Summit H.E. Dr. Majid...
Cidara Therapeutics Announces Expanded and Accelerated Phase 3 Plan for CD388, a Non-Vaccine Preventative of Seasonal Influenza
- Update based on FDA End-of- Phase 2 meeting outcome - Phase 3 study start accelerated by six months, in...
Roche presents new data for OCREVUS and fenebrutinib across broad patient populations at ECTRIMS 2025
OCREVUS subcutaneous maintains consistent benefit-risk profile after two years New late-breaking data confirms OCREVUS significantly reduces disability progression in adults...
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation The fund...
Press release: Availability of the Q3 2025 Aide mémoire
Availability of the Q3 2025 Aide mémoire Paris, France – September 24, 2025. Sanofi announced today that its Q3...
Luminary Labs secures 6 new federal contract vehicles
NEW YORK, Sept. 23, 2025 /PRNewswire/ -- Luminary Labs is thrilled to announce that it has been awarded new federal...